A carregar...

The rise and fall of Dimebon

Dimebon (Latrepirdine) was initially developed in Russia as an over-the-counter antihistamine for allergy treatment. In early 1990s Dimebon was identified as a low affinity NMDA receptor antagonist, patented for treatment of neurodegenerative disorders and licensed by Medivation Inc. Extremely promi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Autor principal: Bezprozvanny, Ilya
Formato: Artigo
Idioma:Inglês
Publicado em: 2010
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3922928/
https://ncbi.nlm.nih.gov/pubmed/21031168
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1358/dnp.2010.23.8.1500435
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!